Digirad's Cardius X-ACT, a dedicated cardiac SPECT system, offers the potential to set new clinical standards with X-ACT attenuation correction. The X-ACT system is based on the high-efficiency Cardius-3 XPO triple-head upright dedicated nuclear cardiac SPECT imaging system.
The INFINITT Cardiology PACS has a user friendly interface, optimized for the cardiology specialists’ workflow. It is a Web-based solution with smart clients, supporting Cine CT and providing reliable measurement tools for Cath, Echo, ECG and CT 3D images.
McKesson’s latest generation Horizon Cardiology (version 12) is designed to incorporate the latest technology and enables extensive new clinical functionality, thus further improving the cardiology department and user workflows.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
February 24, 2009 - Lantheus Medical Imaging Inc. today said a paper published online in the February 2009 issue of the Journal of the American College of Cardiology reinforces the clinical use and impact of its echocardiography contrast agent DEFINITY Vial For (Perflutren Lipid Microsphere) Injectable Suspension in hospitalized and critically ill cardiac patients.
February 24, 2009 - The Medipattern Corp. and NAVIX Diagnostix Inc., a leading provider of vascular ultrasound outsourcing solutions in the northeastern U.S., said that NAVIX will collect data for the development of Medipattern's vascular imaging tool, VasculariQ.
February 23, 2009 - Medtronic Inc. is acquiring CoreValve Inc., developer of a transcatheter, transfemoral aortic valve replacement product, and Ventor Technologies Ltd., a developer of transcatheter heart valve technologies for the treatment of aortic valve disease.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 24, 2009 – Two U.S. healthcare facilities recently signed multiyear contracts with Siemens Healthcare for installation of Siemens’ Soarian Health Information System (HIS) platform. An additional facility also signed a multiyear contract for Soarian and Siemens’ MedSeries4, another fully Web-based HIS designed to meet the needs of community hospitals.
Emageon’s HeartSuite 6.20.1 reported improvements include Web-based clinical reporting expanding reporting from any location, easier navigation and a consistent user interface across all reporting knowledge bases.
February 23, 2009 - Neuisys Imaging System Solutions announced that the FDA has granted 510(k) clearance of the NeuViz 16, a multislice computed tomography (CT) system, which was developed by Philips Neusoft Medical Systems, a joint venture between Royal Philips Electronics of the Netherlands and Neusoft Corporation of China.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Vital Images’ Vitrea Web is a solution exclusive to ViTAL Enterprise customers that provides anywhere access to all of Vital Images’ powerful clinical applications.
NovaRad and Digisonics' PACS/cardiovascular reporting system (CRS) aims to streamline the entire clinical reporting workflow and creates professional, standards-based reports for all cardiovascular modalities. Measurements, velocities, etc.
February 23, 2009 - AMICAS Inc. said today that they have entered into a definitive merger agreement to acquire Emageon Inc.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
February 23, 2009 - Fresno Heart and Surgical Hospital of Fresno, CA today signed a trial agreement for Daxor Corp's Blood Volume Analyzer BVA-100, for its nuclear medicine department.
February 23, 2009 - Alsius Corp. said today it has signed an agreement with a subsidiary of ZOLL Medical Corp. under which Alsius will sell to ZOLL substantially all the assets constituting Alsius’ intravascular temperature management device business for a purchase price of $12 million in cash.
February 23, 2009 - Daiichi Sankyo Co. Ltd and Eli Lilly and Co. announced today that the European Commission granted marketing authorization for EFFIENT (prasugrel) for the prevention of atherothrombotic events in patients with acute coronary syndrome (ACS) undergoing PCI.